DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 019967
» See Plans and Pricing
The generic ingredient in ULTRAVATE is halobetasol propionate. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the halobetasol propionate profile page.
Summary for 019967
Tradename: | ULTRAVATE |
Applicant: | Sun Pharm Inds Inc |
Ingredient: | halobetasol propionate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.05% | ||||
Approval Date: | Dec 27, 1990 | TE: | RLD: | Yes |
Expired US Patents for NDA 019967
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sun Pharm Inds Inc | ULTRAVATE | halobetasol propionate | CREAM;TOPICAL | 019967-001 | Dec 27, 1990 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription